OLBA HEALTHCARE (2689) Q3 2026 earnings summary

Executive summary

• Net sales for the nine months ended March 31, 2026, increased by 3.6% year-over-year to ¥95,777 million.

• Operating profit declined by 3.8% year-over-year to ¥1,244 million.

• Profit attributable to owners of parent decreased by 6.5% year-over-year to ¥872 million.

• Comprehensive income fell by 12.9% year-over-year to ¥796 million.

Financial highlights

• Gross profit rose to ¥10,644 million from ¥10,318 million year-over-year.

• Ordinary profit decreased by 3.8% year-over-year to ¥1,236 million.

• Basic earnings per share for the nine months was ¥147.12, down from ¥157.48 year-over-year.

• Total assets increased to ¥49,360 million as of March 31, 2026, from ¥45,871 million as of June 30, 2025.

• Net assets rose to ¥12,563 million from ¥12,255 million over the same period.

Outlook and guidance

• Full-year net sales forecast for fiscal year ending June 30, 2026, is ¥127,978 million, up 4.3% year-over-year.

• Operating profit is projected at ¥2,000 million, a 1.0% increase year-over-year.

• Profit attributable to owners of parent is forecast at ¥1,321 million, down 7.6% year-over-year.

• Basic earnings per share for the full year is expected to be ¥223.04.

• Annual dividend forecast is ¥80.00 per share.